More patients with ovarian carcinoma carry cancer-predisposing mutations, and in more genes, than previously thought. Relying on family history as an indication for testing would have missed one-fifth of the cases. The study used a quick, accurate genome sequencing method that could become a single test to screen for a broad range of cancers.
























